Parahuleva, N.; Mihaylova, A.; Harizanova, S.; Merdzhanova, Y.; Koleva, M.; Madzharov, V.; Strikova, G.; Uchikova, E.
The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance. Healthcare 2025, 13, 884.
https://doi.org/10.3390/healthcare13080884
AMA Style
Parahuleva N, Mihaylova A, Harizanova S, Merdzhanova Y, Koleva M, Madzharov V, Strikova G, Uchikova E.
The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance. Healthcare. 2025; 13(8):884.
https://doi.org/10.3390/healthcare13080884
Chicago/Turabian Style
Parahuleva, Nikoleta, Anna Mihaylova, Stanislava Harizanova, Yana Merdzhanova, Mariya Koleva, Vasil Madzharov, Gergana Strikova, and Ekaterina Uchikova.
2025. "The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance" Healthcare 13, no. 8: 884.
https://doi.org/10.3390/healthcare13080884
APA Style
Parahuleva, N., Mihaylova, A., Harizanova, S., Merdzhanova, Y., Koleva, M., Madzharov, V., Strikova, G., & Uchikova, E.
(2025). The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance. Healthcare, 13(8), 884.
https://doi.org/10.3390/healthcare13080884
